Fulgent Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-01 11:20:29 ET FLGT

Published on 05/01/2026 at 11:20 am EDT

Fulgent Genetics, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 71.14 million compared to USD 73.46 million a year ago. Net loss was USD 24.83 million compared to USD 11.53 million a year ago.

Basic loss per share from continuing operations was USD 0.8 compared to USD 0.37 a year ago. Diluted loss per share from continuing operations was USD 0.8 compared to USD 0.37 a year ago.